Onderzoeker
Annelies Verbiest
- Disciplines:Laboratoriumgeneeskunde, Palliatieve zorg en zorg rond het levenseinde, Regeneratieve geneeskunde, Andere basiswetenschappen, Andere gezondheidswetenschappen, Verpleegkunde, Andere paramedische wetenschappen, Andere translationele wetenschappen, Andere medische en gezondheidswetenschappen
Affiliaties
- Laboratorium Experimentele Oncologie (Afdeling)
Lid
Vanaf1 okt 2016 → 30 sep 2020
Projecten
1 - 1 of 1
- Moleculaire typering van heldercellig renaalcelcarcinoom en voorspelling van de respons op behandeling met gerichte therapieën tegen de VEGF-receptor, immuun checkpoint inhibitoren en mTOR inhibitoren bij gemetastaseerde ziekte.Vanaf1 okt 2016 → 30 sep 2020Financiering: FWO mandaten, VZW en equivalenten
Publicaties
11 - 20 van 22
- Clear-cell Renal Cell Carcinoma: Molecular Characterization of IMDC Risk Groups and Sarcomatoid Tumors(2019)
Auteurs: Annelies Verbiest, Annouschka Laenen, Patrick Schöffski, Maarten Albersen, Agnieszka Wozniak, Benoit Beuselinck
Pagina's: E981 - E994 - ABCG2 Polymorphism rs2231142 and hypothyroidism in metastatic renal cell carcinoma patients treated with sunitinib(2019)
Auteurs: Diether Lambrechts, Annelies Verbiest, Evelyne Lerut, Brigitte Decallonne, Patrick Schöffski, Oliver Bechter, Benoit Beuselinck
Pagina's: 180 - 188 - Prospective evaluation of hypogonadism in male metastatic renal cell carcinoma patients treated with targeted therapies(2019)
Auteurs: Annelies Verbiest, Kevin Punie, Oliver Bechter, Hans Wildiers, Evelyne Lerut, Herlinde Dumez, Brigitte Decallonne, Paul Clement, Dirk Vanderschueren, Maarten Albersen, et al.
Pagina's: 169 - 179 - Fibroblast Growth Factor Receptor-2 Polymorphism rs2981582 is Correlated With Progression-free Survival and Overall Survival in Patients With Metastatic Clear-cell Renal Cell Carcinoma Treated With Sunitinib(2019)
Auteurs: Maxime Vanmechelen, Diether Lambrechts, Annelies Verbiest, Patrick Schöffski, Herlinde Dumez, Evelyne Lerut, Maarten Albersen, Benoit Beuselinck
Pagina's: E235 - E246 - Tumor molecular characteristics in patients (pts) with international metastatic renal cell carcinoma database consortium (IMDC) good (G) and intermediate/poor (I/P) risk.(2018)
Auteurs: Benoit Beuselinck, Annelies Verbiest, G Couchy, S Job, A de Reynies, S Caruso, V Verkarre, N Rioux-Leclercq, Patrick Schöffski, Y Vano, et al.
Pagina's: viii306 - viii307 - Molecular Subtypes of Clear-cell Renal Cell Carcinoma are Prognostic for Outcome After Complete Metastasectomy(2018)
Auteurs: Annelies Verbiest, Evelyne Lerut, Raymond Oyen, Lorenzo Tosco, Steven Joniau, Hendrik Van Poppel, Dirk Van Raemdonck, Agnieszka Wozniak, Benoit Beuselinck
Pagina's: 474 - 480 - Polymorphisms in the Von Hippel-Lindau Gene Are Associated With Overall Survival in Metastatic Clear-Cell Renal-Cell Carcinoma Patients Treated With VEGFR Tyrosine Kinase Inhibitors(2018)
Auteurs: Annelies Verbiest, Diether Lambrechts, Agnieszka Wozniak, Evelyne Lerut, Benoit Beuselinck
Pagina's: 266 - 273 - Molecular Subtypes of Clear Cell Renal Cell Carcinoma Are Associated With Outcome During Pazopanib Therapy in the Metastatic Setting(2018)
Auteurs: Annelies Verbiest, Evelyne Lerut, Raymond Oyen, Agnieszka Wozniak, Steven Joniau, Hendrik Van Poppel, Benoit Beuselinck
Pagina's: e605 - e612 - Pro-angiogenic gene expression is associated with better outcome on sunitinib in metastatic clear-cell renal cell carcinoma(2018)
Auteurs: Benoit Beuselinck, Annelies Verbiest, Maarten Albersen, Evelyne Lerut, Patrick Schöffski
Pagina's: 498 - 508 - Incidence of medication-related osteonecrosis of the jaw in patients treated with both bone resorption inhibitors and vascular endothelial growth factor receptor tyrosine kinase inhibitors(2018)
Auteurs: Tom van Cann, Annelies Verbiest, Paul Clement, Oliver Bechter, Ludo Willems, Isabel Spriet, Constantinus Politis, Joseph Schoenaers, Herlinde Dumez, Patrick Neven, et al.
Pagina's: 869 - 878